Hold
Thesis MAINTAINING
×
Valuation FAIR
·
Method PEG
LOW 1.6pts from 70 ↓1.1 over 7d stable 15d
Near threshold — system is uncertain

Investment Thesis

Strong — all assumptions holding Maintaining — minor concerns, thesis intact Weak — key assumptions under pressure Broken — critical assumption invalidated
Status MAINTAINING
Conviction 68 / 100
Time Horizon 12-18 months
GROWTH Over the next 12-18 months, BSE Ltd. will achieve accelerated revenue growth and expanding profitability driven by increasing capital market participation, diversification into high-margin services, and enhanced operational efficiency.

Conviction vs. Price

Assumptions

Holding — assumption intact At Risk — evidence weakening Broken — assumption invalidated Critical — if broken, thesis fails
BEAT — exceeded target MEET — met expectations MISS — missed target Insufficient Data
#1 CRITICAL GROWTH AT_RISK 63

BSE's transaction-driven revenues will accelerate driven by sustained retail investor participation, growth in derivatives trading, and expanding SME listings.

GROWTH 50% VOLUME 50%
Quarterly Checkpoint: Q2 FY27 consolidated revenue >= Rs. 1,420 crores, representing YoY growth of >= 48% (Q3 FY26 revenue: Rs. 1,244 cr; management commentary on sustained momentum in capital mobilization and trading volumes)
Thesis Horizon Target: FY27 consolidated revenue >= Rs. 6,400 crores (FY26E: ~Rs. 4,850 cr; mgmt guidance for continued strong momentum and diversification)
#2 CRITICAL GROWTH HOLDING 72

BSE's diversification into mutual fund distribution, data services, and SME listings will drive significant non-transactional revenue growth and margin expansion.

GROWTH 60% PRICING 40%
Quarterly Checkpoint: Q2 FY27 consolidated revenue >= Rs. 1,420 crores, with OPM% >= 61% (Q3 FY26 OPM: 59%; management focus on high-margin data and SME listing growth)
Thesis Horizon Target: FY27 revenue from Data Dissemination, SME Listings, and BSE StAR MF >= Rs. 900 crores (FY26E: ~Rs. 650 cr, based on Q3 FY26 segment performance and expansion plans)
#3 FINANCIAL HEALTH AT_RISK 60

BSE will maintain its debt-free financial health and strong operating cash flow generation, supporting reinvestment and shareholder returns.

DEBT 70% CAPEX 30%
Quarterly Checkpoint: Q2 FY27 Operating Profit >= Rs. 865 crores, with OPM% >= 61% (Q3 FY26 Operating Profit: Rs. 732 cr, OPM: 59%)
Thesis Horizon Target: Maintain debt-free status through FY27, with operating cash flow > Rs. 1,500 crores annually (FY26E OCF: ~Rs. 1,300 cr; low capex intensity < 5% of revenue)
Transcript Checkpoint: Core SGF balance (Q3 FY26: Rs. 1,202 cr)
#4 GOING CONCERN HOLDING 80

BSE will navigate regulatory developments and governance requirements effectively, avoiding material disruptions.

GOING_CONCERN 100%
Quarterly Checkpoint: No material SEBI penalties > Rs. 10 crores or new significant regulatory investigations initiated in Q2 FY27
Thesis Horizon Target: No structural changes to core business model or significant divestiture requirements mandated by SEBI or other regulatory bodies through FY27
Transcript Checkpoint: Successful implementation of closing auction session by August 3, 2026

Recent Developments

Structural Tactical
GROWTH TACTICAL Apr 08, 2026

Safety Controls &amp; Devices IPO Day 3: Issue sails through on QIB, NII demand; check GMP and other details

Safety Controls & Devices SME IPO successfully closed with 1.22x oversubscription, scheduled for listing on April 13, 2026.

GROWTH TACTICAL Apr 07, 2026

Core4 Engineers files draft papers with BSE's SME platform; to raise funds via IPO - MSN

Core4 Engineers filed draft red herring prospectus for an initial public offering on the SME platform.

VOLUME STRUCTURAL Mar 16, 2026

BSE SME exchange crosses 600 listings milestone, cos raise Rs 10,652 crore - MSN

SME exchange reached a milestone of 600 listings, with cumulative capital raised crossing ₹10,652 crore.

GROWTH STRUCTURAL Mar 09, 2026

Explained: Why Wipro, Infosys and other IT stocks rose up to 1% despite Rs 12 lakh crore market selloff

Launched four new factor indices based on the SmallCap 500 universe, including Quality, Momentum, Low Volatility, and Enhanced Value strategies.

GROWTH STRUCTURAL Mar 05, 2026

Innovision IPO price band set at ₹521-548 per share; check key dates, issue details, more

Received SEBI approval to launch derivative contracts on the Sensex Next 30 index, expanding the derivatives product suite.

GROWTH STRUCTURAL Feb 24, 2026

One MobiKwik Systems' subsidiary MSBPL gets BSE nod to launch stock broking business

BSE approved One MobiKwik Systems' subsidiary, MSBPL, to commence stock broking operations effective February 24, 2026.

VOLUME STRUCTURAL Feb 17, 2026

BSE, Angel One shares fall up to 10% after RBI tightens capital market exposure norms

RBI tightened capital market exposure norms effective April 2026, requiring bank guarantees to exchanges be backed by 50% collateral and banning bank funding for proprietary trading.

VOLUME STRUCTURAL Feb 15, 2026

IPO Calendar: Gaudium IVF to open next week as Fractal, Aye Finance head for listing

BSE Q3 FY26 PAT surged 174% to Rs 602 crore, driven by record equity derivatives volume and 87.4% market share in mutual fund transactions.

VOLUME STRUCTURAL Feb 14, 2026

BSE gets Sebi nod to launch 'Focused Midcap Index' futures and options contracts

SEBI approved BSE to launch 'Focused Midcap Index' derivatives; HUL demerger of Kwality Wall's (2.3B shares) confirmed for listing on Feb 16.

GROWTH STRUCTURAL Feb 10, 2026

BSE Q3 Results: Cons PAT skyrockets 174% YoY to Rs 602 crore, revenue soars 62%

Q3 FY26 PAT surged 174% YoY to Rs 602 crore, driven by an 86% increase in transaction revenue from derivatives scaling.

Investor Documents